Insider Trading & Ownership - Bolte Axel

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Bolte Axel
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2022-04-19
Purchase		2022-04-20
4:05 pm		Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer		67,750$3.69$249,998258,575
(Direct)		View
2021-06-24
Sale		2021-06-25
07:58 am		Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer		66,788$0.0001$7291,305
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-07-11
Disposition		2023-07-13
1:55 pm		N/A
N/A		IVERIC bio Inc.ISEEBolte Axel
Director		132,274$00
(Direct)		View
2023-06-13
Option Award		2023-06-15
4:05 pm		N/A
2033-06-12		Inozyme Pharma Inc.INZYBolte Axel
Director		16,000$016,000
(Direct)		View
2023-05-17
Option Award		2023-05-19
5:55 pm		N/A
N/A		IVERIC bio Inc.ISEEBolte Axel
Director		7,500$07,500
(Direct)		View
2023-05-11
Exercise		2023-05-15
4:51 pm		N/A
N/A		IVERIC bio Inc.ISEEBolte Axel
Director		14,588$022,088
(Direct)		View
2023-05-01
Option Award		2023-05-03
08:40 am		N/A
2033-04-30		Inozyme Pharma Inc.INZYBolte Axel
Director		100,000$0100,000
(Direct)		View
2023-03-31
Option Award		2023-04-04
08:40 am		N/A
N/A		Inozyme Pharma Inc.INZYBolte Axel
Director		4,806$2.21266,696
(Direct)		View
2022-09-30
Option Award		2022-10-04
08:00 am		N/A
N/A		Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer		3,315$2.28261,890
(Direct)		View
2022-05-11
Exercise		2022-05-13
6:05 pm		N/A
N/A		IVERIC bio Inc.ISEEBolte Axel
Director		7,500$045,274
(Direct)		View
2022-05-12
Option Award		2022-05-13
6:05 pm		N/A
N/A		IVERIC bio Inc.ISEEBolte Axel
Director		37,774$045,274
(Direct)		View
2022-02-24
Option Award		2022-02-28
07:47 am		N/A
2032-02-23		Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer		275,000$0275,000
(Direct)		View
2021-06-24
Exercise		2021-06-25
07:58 am		N/A
N/A		Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer		66,788$0.98291,305
(Direct)		View
2021-06-24
Exercise		2021-06-25
07:58 am		N/A
2027-06-27		Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer		66,788$0291,305
(Direct)		View
2021-05-19
Option Award		2021-05-20
7:51 pm		N/A
2031-05-18		IVERIC bio Inc.ISEEBolte Axel
Director		23,000$023,000
(Direct)		View
2021-03-04
Option Award		2021-03-17
5:56 pm		N/A
2031-03-03		Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer		117,000$0117,000
(Direct)		View
2021-01-13
Option Award		2021-01-14
4:14 pm		N/A
2030-04-22		Inozyme Pharma Inc.INZYBolte Axel
Chief Executive Officer		225,975$0225,975
(Direct)		View
2020-07-23
Option Award		2020-07-24
4:48 pm		N/A
2030-07-22		Inozyme Pharma Inc.INZYBolte Axel
See Remarks
10% Owner		287,706$0287,706
(Direct)		View

Ownership		2020-07-23
9:20 pm		N/A
N/A		Inozyme Pharma Inc.INZYBolte Axel
See Remarks
10% Owner		0$0649,019
(Direct)		View
2020-06-09
Option Award		2020-06-11
2:02 pm		N/A
N/A		IVERIC bio Inc.ISEEBolte Axel
Director		16,000$016,000
(Direct)		View
2019-05-15
Option Award		2019-05-16
5:10 pm		N/A
2029-05-14		IVERIC bio Inc.ISEEBolte Axel
Director		16,000$016,000
(Direct)		View